Adage Capital Partners’s Immunic IMUX Stock Holding History

Adage Capital Partners’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.15M	Hold	139,860	–	–	﹤0.01%	868
2026 Q1	$1.55M	Hold	139,860	–	–	﹤0.01%	854
2025 Q4	$746K	Hold	139,860	–	–	﹤0.01%	859
2025 Q3	$1.23M	Hold	139,860	–	–	﹤0.01%	830
2025 Q2	$976K	Hold	139,860	–	–	﹤0.01%	799
2025 Q1	$1.52M	Hold	139,860	–	–	﹤0.01%	776
2024 Q4	$1.4M	Sell	139,860 -419,581	-75%	-$5.29M	﹤0.01%	805
2024 Q3	$9.23M	Hold	559,441	–	–	0.02%	621
2024 Q2	$6.21M	Hold	559,441	–	–	0.01%	685
2024 Q1	$7.38M	Buy	+559,441	New	+$7.27M	0.01%	651
2023 Q1	–	Sell	-30,977	Closed	-$434K	–	952
2022 Q4	$434K	Buy	+30,977	New	+$845K	﹤0.01%	863
2022 Q3	–	Sell	-60,090	Closed	-$2.08M	–	1077
2022 Q2	$2.08M	Buy	+60,090	New	+$3.85M	﹤0.01%	875

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Adage Capital Partners's IMUX Position: Q2 2026 in Review

Adage Capital Partners held its Immunic (IMUX) position steady in Q2 2026 at 139,860 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #868.

Adage Capital Partners first reported a position in IMUX in Q2 2022 and has held it in 12 quarters since. The position peaked at $9.23M in Q3 2024. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

Adage Capital Partners held 139,860 shares of Immunic worth $2.15M as of Q2 2026.
Adage Capital Partners left its Immunic share count unchanged in Q2 2026.
Immunic made up ﹤0.01% of Adage Capital Partners's portfolio in Q2 2026, its #868 holding.
Adage Capital Partners first reported a position in Immunic in Q2 2022 and has held it in 12 quarters since.
Adage Capital Partners's Immunic position peaked at $9.23M in Q3 2024.
55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.